Logo
x

Search category

Subscribe Now

technology

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

  • December 21, 2020
Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

  • December 21, 2020
Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases

Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases

  • May 12, 2020
Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases

Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases

  • May 12, 2020
DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

  • February 13, 2020
DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

  • February 13, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.